Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

Authors :: Smolen, J.
Landewe, R.B.
Mease, P.
Brzezicki, J.
Mason, D.
Luijtens, K.
van Vollenhoven, R.F.
Kavanaugh, A.
Schiff, M.
Burmester, G.R.
Strand, V.
Vencovsky, J.
van der Heijde, D.
Source :: Annals of the Rheumatic Diseases. June, 2009, Vol. 68 Issue 6, p797, 8 p.
Publication Year :: 2009

Subjects :: Methotrexate -- Dosage and administration
Methotrexate -- Health aspects
Rheumatoid arthritis -- Drug therapy
Rheumatoid arthritis -- Patient outcomes
Drug therapy -- Usage
Drug therapy -- Patient outcomes
Health
American College of Rheumatology -- Standards

Tools